Company Filing History:
Years Active: 2025
Title: Hatim Sabaawy: Innovator in Pharmaceutical Compounds
Introduction
Hatim Sabaawy is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating serious medical conditions.
Latest Patents
Sabaawy holds a patent for pharmaceutical compounds and therapeutic methods. This invention provides compounds of formula (16) and (17), along with their salts, compositions, and complexes. These compounds are designed for treating cancer, inhibiting BMI1 expression, and addressing Huntington's disease. The compounds, salts, and complexes exhibit potency, permeability, and oral bioavailability, making them particularly effective for treating glioblastoma.
Career Highlights
Hatim Sabaawy is affiliated with Rutgers, the State University of New Jersey. His work at this esteemed institution has allowed him to focus on innovative research in the pharmaceutical sector. His dedication to advancing medical treatments is evident through his patent and ongoing research efforts.
Collaborations
Sabaawy has collaborated with notable colleagues, including David John Augeri and John A Gilleran. These partnerships have contributed to the development of his innovative pharmaceutical compounds.
Conclusion
Hatim Sabaawy is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact cancer treatment and other serious diseases. His contributions to the field exemplify the importance of innovation in healthcare.